The company released its third quarter results Nov. 6.
Three notes on the company’s third quarter performance:
1. Alphatec saw a 24% increase in surgical volume and a 6% increase in average revenue per procedure.
2. The company brought in $150 million in capital to increase investment in implants and instrument sets.
3. The company reported an ending cash balance of $123 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
